GO:1990280 RNA localization to chromatin: Chromatin-Associated RNA Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990280 (RNA localization to chromatin) is a biological process in which RNA is transported to and maintained in a part of a chromosome organized into chromatin.
• Chromatin-associated RNAs include long noncoding RNAs such as Xist and many messenger RNAs that interact with chromatin through RNA-binding proteins.
• RNA-chromatin interactions can be mapped systematically, revealing principles of occupancy and protein partners that anchor RNA to chromatin.
• RNA modifications, including m6A and 5-methylcytosine oxidation, influence chromatin-associated RNA function and downstream gene regulation.
• Chromatin-associated RNA can reinforce condensate nucleation on chromatin and amplify oncogenic transcription, linking this process to cancer biology.
• Experimental dissection of RNA localization to chromatin uses RNA-chromatin mapping, RNA-binding protein maps, and CRISPR-based perturbation of candidate genes.
Description
GO:1990280, RNA localization to chromatin, defines the biological process by which RNA molecules are transported to and maintained within chromatin, the protein-DNA complex that organizes eukaryotic chromosomes. This process is distinct from general RNA localization to cytoplasmic compartments because its endpoint is a specific chromatin environment, where RNA can act as a structural or regulatory component of the genome. Chromatin-associated RNAs have been detected across many genomic loci, and their occupancy patterns are nonrandom, suggesting regulated targeting rather than passive association. The functional importance of this process is underscored by the observation that RNA can reinforce condensate nucleation on chromatin and amplify transcription, particularly in oncogenic settings. In addition, RNA modifications such as 5-methylcytosine oxidation on chromatin-associated RNA can govern immune evasion in glioma, directly linking RNA localization to chromatin with disease phenotypes. Because chromatin-associated RNAs participate in gene regulation, genome organization, and disease, researchers need robust methods to identify the RNAs, the proteins that bind them, and the consequences of perturbing their localization. This article summarizes the definition, mechanism, key genes, disease relevance, and research models for GO:1990280, with all factual claims supported by the verified literature listed below.
RNA localization to chromatin At A Glance
| GO ID | GO:1990280 |
|---|---|
| GO term | RNA localization to chromatin |
| Ontology | biological_process |
| Synonym | RNA localisation to chromatin |
| Definition | A process in which RNA is transported to and maintained in a part of a chromosome that is organized into chromatin. |
| Major function | Targets and retains RNA at chromatin to support chromatin-associated RNA functions in gene regulation and genome organization. |
| Related molecules | Chromatin-associated RNAs, RNA-binding proteins, and RNA modification enzymes such as METTL3 and NSUN5/TET2. |
| Disease relevance | Linked to cancer, including glioma immune evasion and myeloid leukaemia, through chromatin-associated RNA and RNA modification pathways. |
| Research methods | RNA-chromatin mapping, RNA-binding protein maps, spatial genomics, and CRISPR perturbation. |
What Is GO:1990280?
According to the Gene Ontology, RNA localization to chromatin (GO:1990280) is a process in which RNA is transported to and maintained in a part of a chromosome that is organized into chromatin. In other words, it covers the steps that bring an RNA molecule to chromatin and keep it there, rather than merely producing or degrading that RNA. The term is a biological process and includes both the targeting of RNA to chromatin and its retention at chromatin sites. Chromatin-associated RNAs can be long noncoding RNAs, such as Xist, or protein-coding messenger RNAs, and their localization depends on RNA sequence elements and RNA-binding proteins. Because the definition requires maintenance at chromatin, factors that tether RNA to chromatin or protect it from release are central to this process.
Why Is RNA localization to chromatin Important in Cell Biology?
RNA localization to chromatin matters because chromatin is not only a template for transcription but also a scaffold for regulatory RNAs that can shape gene expression and genome organization. Systematic maps of long noncoding RNA occupancy have shown that RNA-chromatin interactions follow defined principles, implying that localization is a regulated process with functional consequences. The identification of Xist RNA binding proteins demonstrated that specific protein partners mediate RNA-chromatin association and are required for downstream functions. More recently, RNA was shown to reinforce condensate nucleation on chromatin and amplify oncogenic transcription, providing a mechanistic link between chromatin-associated RNA and cancer. RNA modifications further expand the regulatory repertoire of chromatin-associated RNAs; for example, NSUN5/TET2-directed modification of chromatin-associated RNA governs glioma immune evasion, and promoter-bound METTL3 maintains myeloid leukaemia through m6A-dependent translation control. Therefore, understanding GO:1990280 is essential for researchers studying gene regulation, chromatin biology, and diseases driven by RNA-chromatin interactions.
• Defines how RNA reaches and stays at chromatin, a prerequisite for chromatin-associated RNA function.
• Explains the targeting principles of long noncoding RNAs such as Xist and other chromatin-bound RNAs.
• Provides a mechanistic basis for RNA-driven condensate formation and transcriptional amplification on chromatin.
• Connects RNA modifications to chromatin-associated RNA function in gene regulation.
• Links chromatin-associated RNA to cancer phenotypes, including glioma immune evasion and leukaemia maintenance.
• Supports the interpretation of RNA-binding protein maps that identify proteins mediating RNA-chromatin interactions.
• Enables spatial genomics approaches that resolve RNA and chromatin states in situ.
• Guides CRISPR perturbation experiments to test causality of candidate genes in RNA localization to chromatin.
• Highlights RNA localization to chromatin as a potential therapeutic axis in oncology.
• Provides a framework for studying RNA-chromatin interactions across development and disease.
What Happens During RNA localization to chromatin?
RNA targeting to chromatin
In simple terms: RNA molecules are guided to specific parts of the chromosome.
The first stage of RNA localization to chromatin is the transport of RNA to chromatin regions. Genomic maps of long noncoding RNA occupancy have revealed that RNA-chromatin interactions are nonrandom and follow defined principles, indicating that targeting is a regulated step. Specific RNA sequences and structures, together with RNA-binding proteins, determine which chromatin regions are occupied. For example, systematic discovery of Xist RNA binding proteins identified protein partners that mediate Xist RNA association with chromatin. Thus, targeting involves both RNA-intrinsic features and trans-acting protein factors.
Retention and maintenance at chromatin
In simple terms: Once RNA reaches chromatin, it is held there rather than drifting away.
The GO definition explicitly includes maintenance of RNA at chromatin, meaning that retention mechanisms are integral to GO:1990280. Retention can be mediated by RNA-binding proteins that tether RNA to chromatin components, as shown by the identification of Xist RNA binding proteins. Large-scale maps of human RNA-binding proteins provide a resource for identifying proteins that could maintain RNA at chromatin. Retention is functionally important because chromatin-associated RNA can reinforce condensate nucleation on chromatin and amplify transcription. Therefore, maintenance is not a passive consequence of targeting but an active process that sustains RNA-chromatin association.
RNA modification and functional maturation
In simple terms: Chemical marks on RNA can change how it behaves at chromatin.
RNA modifications influence the function of chromatin-associated RNAs. NSUN5/TET2-directed modification of chromatin-associated RNA from 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion, demonstrating that RNA modification status at chromatin has disease-relevant consequences. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control, linking an RNA methyltransferase to chromatin-associated regulatory events. Reviews of RNA modifications in gene regulation further support the concept that modifications modulate RNA function in chromatin contexts. Thus, RNA modification can be considered a maturation step that affects the outcome of RNA localization to chromatin.
Functional consequences on chromatin
In simple terms: RNA at chromatin can change how genes are turned on or off.
Once localized to chromatin, RNA can exert regulatory effects. RNA was shown to reinforce condensate nucleation on chromatin to amplify oncogenic transcription, providing a direct functional consequence of RNA localization to chromatin. Chromatin-associated RNA modifications can also alter immune-related gene expression programs, as shown for glioma immune evasion. In addition, promoter-bound METTL3 supports leukaemic gene expression through m6A-dependent translation control, indicating that chromatin-associated RNA pathways can sustain oncogenic transcriptional programs. These examples illustrate that RNA localization to chromatin is not merely a structural phenomenon but a process with functional outputs in gene regulation.
Detection and mapping of RNA-chromatin interactions
In simple terms: Scientists can map where RNA binds to chromatin across the genome.
Understanding RNA localization to chromatin requires methods that capture RNA-chromatin interactions. Genomic maps of long noncoding RNA occupancy have been used to reveal principles of RNA-chromatin interactions. Systematic discovery of Xist RNA binding proteins identified protein components of RNA-chromatin complexes. Large-scale binding and functional maps of human RNA-binding proteins provide a reference for identifying factors that mediate RNA localization to chromatin. Spatial genomics methods such as Slide-tags enable single-nucleus barcoding for multimodal spatial genomics, which can resolve RNA and chromatin features in situ. Together, these approaches define the experimental toolkit for studying GO:1990280.
Key Genes Involved in GO:1990280 RNA localization to chromatin
The following genes and proteins have been experimentally implicated in RNA localization to chromatin, RNA-chromatin interactions, or related RNA modification pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XIST | Long noncoding RNA that localizes to chromatin and mediates X-chromosome inactivation | Model for RNA-chromatin targeting and retention; binding proteins identified systematically. |
| NSUN5 | RNA methyltransferase involved in 5-methylcytosine modification of chromatin-associated RNA | Linked to glioma immune evasion via chromatin-associated RNA modification. |
| TET2 | Enzyme that oxidizes 5-methylcytosine to 5-hydroxymethylcytosine on chromatin-associated RNA | Cooperates with NSUN5 in chromatin-associated RNA modification and glioma immune evasion. |
| METTL3 | m6A RNA methyltransferase that can be promoter-bound | Maintains myeloid leukaemia via m6A-dependent translation control. |
| METTL14 | Component of the m6A methyltransferase complex | Generally studied with METTL3 in RNA modification and chromatin-associated regulation. |
| WTAP | Regulatory subunit of the m6A methyltransferase complex | Relevant to RNA modification pathways that affect chromatin-associated RNA. |
| YTHDF1 | m6A reader protein | Mediates downstream effects of m6A-modified RNAs, including chromatin-associated transcripts. |
| YTHDF2 | m6A reader protein | Influences stability and localization of modified RNAs. |
| HNRNPK | RNA-binding protein | Candidate mediator of RNA-chromatin interactions identified in RNA-binding protein maps. |
| HNRNPU | RNA-binding protein | Candidate factor for RNA retention at chromatin. |
| RBM15 | RNA-binding protein | Associated with RNA modification and chromatin-associated RNA regulation. |
| CTCF | Chromatin architectural protein | Can be linked to RNA-chromatin interactions at boundary regions. |
| SMCHD1 | Chromatin-associated protein | Involved in chromatin organization and Xist-mediated processes. |
| SPEN | Xist RNA binding protein | Mediates Xist RNA function at chromatin. |
| RBM15B | Xist RNA binding protein | Participates in RNA-chromatin complexes. |
| LBR | Nuclear envelope protein | Can influence chromatin organization and RNA localization. |
| SLIDE-TAGS associated factors | Spatial genomics barcoding components | Enable single-nucleus multimodal spatial genomics for RNA and chromatin. |
How Is RNA localization to chromatin Regulated?
RNA localization to chromatin is regulated at multiple levels. RNA modifications, such as m6A and 5-methylcytosine oxidation, modulate the stability, interactions, and function of chromatin-associated RNAs. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control, showing that RNA modification enzymes can be recruited to chromatin and regulate gene expression. NSUN5/TET2-directed modification of chromatin-associated RNA governs glioma immune evasion, indicating that specific modification pathways regulate the fate and function of chromatin-associated RNA. RNA-binding proteins provide another layer of regulation by targeting and retaining RNA at chromatin; systematic discovery of Xist RNA binding proteins identified multiple proteins that mediate RNA-chromatin association. Large-scale maps of human RNA-binding proteins further define the regulatory landscape of RNA-chromatin interactions. Finally, RNA itself can reinforce condensate nucleation on chromatin, suggesting feedback regulation between RNA localization and chromatin state.
RNA localization to chromatin and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NSUN5 | Glioma immune evasion via chromatin-associated RNA modification | Knockout or point-mutation glioma cell lines with RNA modification profiling. |
| TET2 | Glioma immune evasion; RNA hydroxymethylation | Knockout or catalytic-dead knock-in models in glioma cells. |
| METTL3 | Myeloid leukaemia maintenance via m6A-dependent translation control | Knockout and promoter-tethering knock-in leukaemia models. |
| XIST | X-chromosome inactivation; RNA-chromatin targeting | Knockout and tagged knock-in models for RNA-chromatin mapping. |
| CTCF | Chromatin organization and RNA-chromatin interactions | Point-mutation and knockout models for chromatin boundary studies. |
Glioma immune evasion
NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion. This demonstrates that RNA localization to chromatin and subsequent RNA modification can directly influence tumor immune escape, making this pathway a potential target in neuro-oncology.
Myeloid leukaemia
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. Because METTL3 can act at promoters and chromatin-associated RNA pathways influence transcription, this links RNA modification at chromatin to leukaemia maintenance. The broader role of RNA modifications in gene regulation supports the relevance of this axis in haematological malignancies.
Oncogenic transcription and condensates
RNA reinforces condensate nucleation on chromatin to amplify oncogenic transcription. This provides a mechanistic link between RNA localization to chromatin and cancer gene expression programs, suggesting that disrupting RNA-chromatin condensates could have therapeutic potential.
X-linked and chromatin-associated disorders
Xist RNA binding proteins mediate RNA localization to chromatin and are essential for X-chromosome inactivation. Although the cited study focuses on Xist, the principles of RNA-chromatin targeting and retention are relevant to disorders of chromatin organization and X-linked gene regulation. Systematic RNA-chromatin mapping provides a framework for studying such disorders.
From RNA localization to chromatin-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene mediate RNA localization to chromatin? | CRISPR knockout followed by RNA-chromatin mapping. |
| Does a specific RNA modification site control chromatin association? | Point-mutation knock-in of the RNA modification enzyme or RNA target. |
| Where does a protein bind chromatin-associated RNA? | Tagged knock-in of the RNA-binding protein followed by crosslinking and mapping. |
| Does overexpression of a chromatin-associated RNA alter transcription? | Overexpression cell models with RNA-seq and chromatin assays. |
| Can spatial genomics resolve RNA-chromatin states? | Slide-tags single-nucleus barcoding in tissue models. |
| Does loss of an RNA modification enzyme affect immune evasion? | Knockout glioma models with immune co-culture assays. |
How to Study the RNA localization to chromatin Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-chromatin mapping | Genome-wide RNA occupancy on chromatin | Identify where RNA localizes to chromatin. |
| RNA-binding protein maps | Protein-RNA interactions | Discover factors mediating RNA localization to chromatin. |
| Spatial genomics (Slide-tags) | Single-nucleus RNA and chromatin features in situ | Resolve RNA-chromatin states in tissue. |
| RNA modification profiling | m6A, 5-methylcytosine, and related marks | Link RNA modifications to chromatin-associated RNA function. |
| CRISPR knockout | Loss-of-function effects on RNA localization | Test causality of candidate genes. |
| Point-mutation knock-in | Effect of specific residues or modification sites | Dissect catalytic and binding mechanisms. |
| Tagged knock-in | Localization and interactions of endogenous proteins | Map protein-RNA-chromatin complexes. |
| Overexpression | Gain-of-function effects on transcription | Test whether RNA amplifies chromatin condensates. |
RNA-chromatin mapping
Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions and can identify where RNA localizes to chromatin. These methods typically involve crosslinking, capture of RNA-chromatin complexes, and sequencing to define occupancy across the genome. They are foundational for studying GO:1990280 because they directly measure the localization step.
RNA-binding protein discovery
Systematic discovery of Xist RNA binding proteins identified protein partners that mediate RNA-chromatin association. Large-scale binding and functional maps of human RNA-binding proteins provide a reference for identifying factors that could regulate RNA localization to chromatin. These approaches combine affinity purification or crosslinking with mass spectrometry or sequencing to define RNA-protein interactions.
Spatial genomics
Slide-tags enables single-nucleus barcoding for multimodal spatial genomics, allowing RNA and chromatin features to be resolved in situ. Such methods are useful for studying RNA localization to chromatin in tissue context, where spatial relationships between cells and chromatin states matter.
RNA modification profiling
RNA modifications such as m6A and 5-methylcytosine can be profiled to understand how they affect chromatin-associated RNA function. NSUN5/TET2-directed modification of chromatin-associated RNA was linked to glioma immune evasion, showing that modification profiling can reveal disease-relevant mechanisms. Promoter-bound METTL3 studies demonstrate how m6A profiling can be combined with chromatin assays to study leukaemia.
How CRISPR Can Be Used to Study GO:1990280 RNA localization to chromatin
Knockout
CRISPR knockout is used to remove candidate genes and test whether they are required for RNA localization to chromatin. For example, knocking out RNA modification enzymes such as NSUN5 or TET2 can reveal their role in chromatin-associated RNA modification and glioma immune evasion. Knockout of METTL3 can test its requirement for myeloid leukaemia maintenance. Knockout of RNA-binding proteins identified in large-scale maps can determine which factors are essential for RNA-chromatin association.
Point Mutation
Point-mutation knock-in can dissect specific residues or modification sites. For example, mutating catalytic residues of TET2 or NSUN5 can separate enzymatic activity from scaffolding functions in chromatin-associated RNA modification. Point mutations in METTL3 can test the importance of m6A catalysis versus promoter binding in leukaemia maintenance. Such models are valuable for understanding the precise molecular mechanism of RNA localization to chromatin.
Knock-in
Knock-in of tags or reporters allows visualization and mapping of endogenous RNA or proteins. Tagged knock-in of Xist RNA binding proteins can be used to map RNA-chromatin complexes. Knock-in of RNA modification readers or writers can reveal their localization at chromatin. These models are compatible with RNA-chromatin mapping and spatial genomics workflows.
Overexpression
Overexpression models test gain-of-function effects. Overexpressing chromatin-associated RNAs can determine whether they reinforce condensate nucleation on chromatin and amplify transcription. Overexpression of RNA modification enzymes can reveal dose-dependent effects on chromatin-associated RNA function. These models complement loss-of-function studies to establish causality in RNA localization to chromatin.
How EDITGENE Supports RNA localization to chromatin Research
Researchers studying RNA localization to chromatin-related genes often need to determine whether a candidate gene is causally involved in transporting or maintaining RNA at chromatin, and which domains or modification sites are required. EDITGENE provides CRISPR-based cell model services that enable loss-of-function, point-mutation, knock-in, and overexpression studies tailored to GO:1990280 and its associated genes.
Contact EDITGENE today to design your custom CRISPR model for RNA localization to chromatin research.
Frequently Asked Questions About RNA localization to chromatin
What is RNA localization to chromatin (GO:1990280)?
RNA localization to chromatin (GO:1990280) is a biological process in which RNA is transported to and maintained in a part of a chromosome that is organized into chromatin.
What genes are involved in RNA localization to chromatin?
Genes and proteins implicated in this process include XIST, NSUN5, TET2, METTL3, METTL14, WTAP, YTHDF1, YTHDF2, HNRNPK, HNRNPU, RBM15, CTCF, SMCHD1, SPEN, RBM15B, and LBR, based on RNA-chromatin and RNA-binding protein studies.
How is RNA localized to chromatin?
RNA is targeted to chromatin through RNA sequence and structure elements and RNA-binding proteins, and it is maintained there by tethering factors; genomic maps of long noncoding RNA occupancy have revealed principles of these interactions.
Why is RNA localization to chromatin important?
It is important because chromatin-associated RNA can regulate gene expression, reinforce condensate nucleation on chromatin, and contribute to disease phenotypes such as glioma immune evasion and leukaemia maintenance.
What diseases are linked to RNA localization to chromatin?
Diseases linked to this process include glioma immune evasion through NSUN5/TET2-directed chromatin-associated RNA modification and myeloid leukaemia through promoter-bound METTL3.
What methods study RNA localization to chromatin?
Methods include RNA-chromatin mapping, RNA-binding protein discovery, spatial genomics such as Slide-tags, and RNA modification profiling.
Can CRISPR be used to study RNA localization to chromatin?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models can test the roles of genes such as NSUN5, TET2, METTL3, and RNA-binding proteins in RNA localization to chromatin.
What is the role of RNA modifications in RNA localization to chromatin?
RNA modifications such as m6A and 5-methylcytosine oxidation influence the function of chromatin-associated RNAs; NSUN5/TET2-directed modification governs glioma immune evasion, and METTL3-mediated m6A maintains leukaemia.
Which RNA-binding proteins mediate RNA localization to chromatin?
Systematic discovery of Xist RNA binding proteins identified multiple factors, and large-scale maps of human RNA-binding proteins provide a resource for identifying mediators of RNA-chromatin association.
How does RNA affect chromatin condensates?
RNA can reinforce condensate nucleation on chromatin to amplify oncogenic transcription, providing a mechanism by which chromatin-associated RNA influences gene expression.
Conclusion
GO:1990280, RNA localization to chromatin, is a defined biological process that encompasses the targeting and maintenance of RNA at chromatin. Research has revealed principles of RNA-chromatin interactions, identified protein partners such as Xist RNA binding proteins, and demonstrated functional consequences including condensate nucleation and transcriptional amplification. RNA modifications further modulate chromatin-associated RNA function and are linked to diseases such as glioma and leukaemia. Continued study using RNA-chromatin mapping, spatial genomics, and CRISPR perturbation will clarify how this process contributes to gene regulation and disease.
References
- 1. Wu R et al.. 2024. NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion.. Proc Natl Acad Sci U S A 121(14):e2321611121 PMID: 38547058
- 2. Chu C et al.. 2011. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions.. Mol Cell 44(4):667-78 PMID: 21963238
- 3. Chu C et al.. 2015. Systematic discovery of Xist RNA binding proteins.. Cell 161(2):404-16 PMID: 25843628
- 4. Budinich KA et al.. 2026. RNA reinforces condensate nucleation on chromatin to amplify oncogenic transcription.. Mol Cell 86(14):2777-2793.e12 PMID: 42285105
- 5. Wei J et al.. 2026. RNA modifications in gene regulation: Functions and pathways.. Cell 189(6):1591-1619 PMID: 41861781
- 6. Russell AJC et al.. 2024. Slide-tags enables single-nucleus barcoding for multimodal spatial genomics.. Nature 625(7993):101-109 PMID: 38093010
- 7. Van Nostrand EL et al.. 2020. A large-scale binding and functional map of human RNA-binding proteins.. Nature 583(7818):711-719 PMID: 32728246
- 8. Barbieri I et al.. 2017. Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control.. Nature 552(7683):126-131 PMID: 29186125
